JP2013529913A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013529913A5 JP2013529913A5 JP2013512943A JP2013512943A JP2013529913A5 JP 2013529913 A5 JP2013529913 A5 JP 2013529913A5 JP 2013512943 A JP2013512943 A JP 2013512943A JP 2013512943 A JP2013512943 A JP 2013512943A JP 2013529913 A5 JP2013529913 A5 JP 2013529913A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- protein
- helper virus
- helper
- protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000700605 Viruses Species 0.000 claims 35
- 108090000623 proteins and genes Proteins 0.000 claims 25
- 102000004169 proteins and genes Human genes 0.000 claims 25
- 238000000034 method Methods 0.000 claims 17
- 239000002245 particle Substances 0.000 claims 14
- 239000004365 Protease Substances 0.000 claims 8
- 108091005804 Peptidases Proteins 0.000 claims 7
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 7
- 235000019419 proteases Nutrition 0.000 claims 7
- 101150076840 PolI gene Proteins 0.000 claims 4
- 238000012217 deletion Methods 0.000 claims 4
- 230000037430 deletion Effects 0.000 claims 4
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 claims 3
- 108010067372 Pancreatic elastase Proteins 0.000 claims 3
- 102000016387 Pancreatic elastase Human genes 0.000 claims 3
- 108090000631 Trypsin Proteins 0.000 claims 3
- 102000004142 Trypsin Human genes 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 238000012986 modification Methods 0.000 claims 3
- 230000004048 modification Effects 0.000 claims 3
- 239000012588 trypsin Substances 0.000 claims 3
- 238000003776 cleavage reaction Methods 0.000 claims 2
- 230000001086 cytosolic effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000007017 scission Effects 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 108090000317 Chymotrypsin Proteins 0.000 claims 1
- 241000711573 Coronaviridae Species 0.000 claims 1
- 101150039660 HA gene Proteins 0.000 claims 1
- 102000014150 Interferons Human genes 0.000 claims 1
- 108010050904 Interferons Proteins 0.000 claims 1
- 101150080862 NA gene Proteins 0.000 claims 1
- 101150076514 NS gene Proteins 0.000 claims 1
- 101150033828 NS1 gene Proteins 0.000 claims 1
- 108090000526 Papain Proteins 0.000 claims 1
- 102000017143 RNA Polymerase I Human genes 0.000 claims 1
- 108010013845 RNA Polymerase I Proteins 0.000 claims 1
- 102000009572 RNA Polymerase II Human genes 0.000 claims 1
- 108010009460 RNA Polymerase II Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 238000004458 analytical method Methods 0.000 claims 1
- 230000000890 antigenic effect Effects 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 229960002376 chymotrypsin Drugs 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 241001493065 dsRNA viruses Species 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 108010028403 hemagglutinin esterase Proteins 0.000 claims 1
- 229940079322 interferon Drugs 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 235000019834 papain Nutrition 0.000 claims 1
- 229940055729 papain Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10164779.0 | 2010-06-02 | ||
| EP10164779 | 2010-06-02 | ||
| PCT/EP2011/059284 WO2011151470A2 (en) | 2010-06-02 | 2011-06-06 | Novel method for generation of rna virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013529913A JP2013529913A (ja) | 2013-07-25 |
| JP2013529913A5 true JP2013529913A5 (https=) | 2014-07-10 |
Family
ID=44627454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013512943A Withdrawn JP2013529913A (ja) | 2010-06-02 | 2011-06-06 | Ｒｎａウィルスの作製のための方法及びヘルパーウィルス |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130183740A1 (https=) |
| EP (1) | EP2576773A2 (https=) |
| JP (1) | JP2013529913A (https=) |
| KR (1) | KR20130115105A (https=) |
| CN (1) | CN103237890A (https=) |
| CA (1) | CA2801268A1 (https=) |
| EA (1) | EA201201620A1 (https=) |
| WO (1) | WO2011151470A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103865923B (zh) * | 2014-01-28 | 2017-04-26 | 中国人民解放军第三0二医院 | 流感病毒为载体的HAdV嵌合疫苗的制备及其应用 |
| CN109097341B (zh) * | 2018-08-28 | 2021-09-24 | 青岛农业大学 | 一种同时表达ha和hef的复制缺陷型重组流感病毒 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2737501B1 (fr) * | 1995-07-31 | 1997-10-24 | Transgene Sa | Nouveaux virus auxiliaires pour la preparation de vecteurs viraux recombinants |
| ATE384126T1 (de) | 1998-06-12 | 2008-02-15 | Sinai School Medicine | Interferon induzierende genetisch veränderte attenuierte viren |
| KR100637937B1 (ko) | 1998-06-12 | 2006-10-23 | 마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 | 변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스 |
| WO2000056914A1 (en) | 1999-03-24 | 2000-09-28 | Gene Therapy Systems, Inc. | Method for generating transcriptionally active dna fragments |
| EP1820853B1 (en) | 1999-04-06 | 2011-09-21 | Wisconsin Alumni Research Foundation | Recombinant influenza viruses for vaccines and gene therapy |
| ES2278621T5 (es) | 1999-07-14 | 2011-02-02 | Mount Sinai School Of Medicine Of New York University | Reconstrucción in vitro de virus arn segmentados de polaridad negativa. |
| MXPA02010642A (es) * | 2000-04-28 | 2004-05-17 | St Jude Children S Res Hospital | Sistema de transfeccion de adn para la generacion de virus de influenza infeccioso. |
| EP1470218B1 (en) * | 2001-05-17 | 2010-07-07 | Universiteit Utrecht | Corona-virus-like particles comprising functionally deleted genomes |
| DE10248301A1 (de) * | 2002-10-16 | 2004-04-29 | Philipps-Universität Marburg | Herstellung eines Lebend-Impfstoffes gegen Influenza-Viren |
| EP2295542B1 (en) * | 2004-12-24 | 2013-01-30 | Abbott Biologicals B.V. | Rescue of influenza virus |
| EP2045323A1 (en) * | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
| EP2048237A1 (en) * | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
| US8815252B2 (en) * | 2008-11-25 | 2014-08-26 | Baxter Healthcare Sa | Method for production of pH stable enveloped viruses |
| EP2233568A1 (en) * | 2009-03-19 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade AG | Novel method for generation of RNA virus |
| EP2233152A1 (en) * | 2009-03-24 | 2010-09-29 | Avir Green Hills Biotechnology Research Development Trade Ag | High growth reassortant influenza A virus |
| US9771564B2 (en) * | 2009-07-22 | 2017-09-26 | Nanotherapeutics, Inc. | Influenza virus |
-
2011
- 2011-06-06 JP JP2013512943A patent/JP2013529913A/ja not_active Withdrawn
- 2011-06-06 WO PCT/EP2011/059284 patent/WO2011151470A2/en not_active Ceased
- 2011-06-06 EP EP11727412.6A patent/EP2576773A2/en not_active Withdrawn
- 2011-06-06 US US13/701,164 patent/US20130183740A1/en not_active Abandoned
- 2011-06-06 EA EA201201620A patent/EA201201620A1/ru unknown
- 2011-06-06 CN CN201180041228XA patent/CN103237890A/zh active Pending
- 2011-06-06 CA CA2801268A patent/CA2801268A1/en not_active Abandoned
- 2011-06-06 KR KR1020127033905A patent/KR20130115105A/ko not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Habjan et al. | T7 RNA polymerase-dependent and-independent systems for cDNA-based rescue of Rift Valley fever virus | |
| Schelle et al. | Selective replication of coronavirus genomes that express nucleocapsid protein | |
| Devignot et al. | A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus | |
| Westgeest et al. | Genomewide analysis of reassortment and evolution of human influenza A (H3N2) viruses circulating between 1968 and 2011 | |
| Hoffmann et al. | Differential sensitivity of bat cells to infection by enveloped RNA viruses: coronaviruses, paramyxoviruses, filoviruses, and influenza viruses | |
| Luczo et al. | Molecular pathogenesis of H5 highly pathogenic avian influenza: the role of the haemagglutinin cleavage site motif | |
| Prins et al. | Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function | |
| Kohl et al. | Complementarity, sequence and structural elements within the 3′ and 5′ non-coding regions of the Bunyamwera orthobunyavirus S segment determine promoter strength | |
| Tsuda et al. | An improved reverse genetics system to overcome cell-type–dependent Ebola virus genome plasticity | |
| RU2008101367A (ru) | Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках | |
| Rodríguez et al. | Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues | |
| Jaimes et al. | A fluorogenic peptide cleavage assay to screen for proteolytic activity: applications for coronavirus spike protein activation | |
| JP2019511918A (ja) | ヒト化ｔｍｐｒｓｓ遺伝子を有する齧歯類 | |
| De Baets et al. | A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody | |
| CN104710534A (zh) | 重组HBc融合蛋白 | |
| Song et al. | Establishment of Vero cell RNA polymerase I-driven reverse genetics for Influenza A virus and its application for pandemic (H1N1) 2009 influenza virus vaccine production | |
| Accardi et al. | Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates | |
| El Najjar et al. | Analysis of cathepsin and furin proteolytic enzymes involved in viral fusion protein activation in cells of the bat reservoir host | |
| JP2013529913A5 (https=) | ||
| KR20110101137A (ko) | Ｒｎａ 바이러스의 생성을 위한 신규한 방법 | |
| JP2014533115A5 (https=) | ||
| EP3708650B1 (en) | Cells for producing influenza virus and method for producing influenza virus | |
| JPWO2020004425A1 (ja) | インフルエンザウイルスの培養方法 | |
| Cárdenas et al. | Rapid sequence modification in the highly polymorphic region (HPR) of the hemagglutinin gene of the infectious salmon anaemia virus (ISAV) suggests intra‐segmental template switching recombination | |
| CN110106193A (zh) | 一种具有低受体结合活性的高致病性h7n9禽流感病毒抗原及其制备方法 |